Total Funding: $106M
Headquarters: Ann Arbor, Michigan, United States
Funding Status: M&A
Estimated Revenue: Less than $1M
Last Funding Type: Venture - Series Unknown
Technology: Neurological Disorders
Investors Number: 12
Founded Date: 2009
Industry: Gene Therapy